Morphosys AG - ADR (MOR) Live Stock Price, Forecast & News | FX Empire

Advertisement

Advertisement

Morphosys AG - ADR
MOR
(Nasdaq - US)
N/A
17.89
+0.38 (+2.17%)
in:usd•As of: May 02, 2024 15:59 UTC -4
Open
17.53
High
17.95
Low
17.50

Stats

Prev. Close

17.51

Open

17.53

Day's Range

17.50 - 17.95

52 Week Range

4.19 - 18.31

YTD Change

80.71%

1 Year Change

234.39%

Market Cap

2.69B

P/E Ratio

N/A

Volume

23,313

Beta

1.15

Sector

Health Technology

Industry

Economic CalendarAll Events

Time zone: GMT

Thursday, May 2nd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Nonfarm Productivity QoQ PrelQ1	Medium	0.3%	0.8%	3.5%
12:30	USD	Initial Jobless ClaimsApr/27	Medium	208K	212K	208K
12:30	USD	Unit Labour Costs QoQ PrelQ1	Medium	4.7%	3.3%	0.0%
14:00	USD	Factory Orders MoMMar	Medium	1.6%	1.6%	1.2%

Friday, May 3rd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Average Hourly Earnings MoMApr	Medium		0.3%	0.3%
12:30	USD	Average Hourly Earnings YoY	Medium		4%	4.1%
12:30	USD	Participation RateApr	Medium		62.7%	62.7%

Latest News

Seeking AlphaMay 1, 2024

MorphoSys: Hold Rating Until The Novartis Deal Closes

MOR+2.17%

featured

Seeking AlphaMar 14, 2024

MorphoSys AG (MOR) Q4 2023 Earnings Call Transcript

MOR+2.17%

featured

Zacks Investment ResearchMar 8, 2024

5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024

MOR+2.17%

featured

Zacks Investment ResearchMar 4, 2024

MorphoSys AG Unsponsored ADR (MOR) is a Great Momentum Stock: Should You Buy?

MOR+2.17%

featured

Zacks Investment ResearchFeb 15, 2024

What Makes MorphoSys AG Unsponsored ADR (MOR) a Strong Momentum Stock: Buy Now?

MOR+2.17%

featured

InvestopediaFeb 6, 2024

Novartis to acquire German Biotech MorphoSys for $2.9B, Expanding Cancer Drug Pipeline

MOR+2.17%

Data Vendor: Xignite Logo

Stocks

Loading

Loading

Trade With A Regulated Broker